✦ LIBER ✦

Paclitaxel/epirubicin/etoposide in patients with extensive-disease small-cell lung cancer (SCLC)

✍ Scribed by Baldini, E.; Chella, A.; Del Freo, A.; Gragnani, F.; Angeletti, C.A.; Conte, P.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-559 Epirubicin/Paclitaxel/Etoposide (E

✍ Fabbri, Alessandro; Innocenti, Florio; Pennucci, Maria Cristina; Del Freo, Alfon 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Cyclophosphamide, epirubicin and etoposi

✍ Jassem, J.; Karnicka-Mlodkowska, H.; Jassem, E.; Badzio, A.; Szczepek, B.; Wiatr 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Cisplatin–etoposide alternating with top

✍ Mavroudis, D; Veslemes, M; Kouroussis, Ch; Tzanakis, N; Ferdoutsis, E; Toumbis, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Carboplatin/Etoposide/Paclitaxel in the

✍ Harvey B. Niell; Michael C. Perry; Gerald Clamon; Jeffrey Crawford; Antonius A. 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 159 KB

Determining carboplatin/etoposide dosage

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 160 KB